Can the flu shot cause the flu? You may be tempted to skip your flu shot this season because of scheduling issues, a fear of needles or another reason. But misconceptions and misinformation — ...

A new variant of influenza H3N2 is spreading in other countries. But that could mean the U.S. is in for a rough flu season. The mutated strain, known as subclade K, is causing a surge in cases in the ...

Flu cases in the U.K. are already triple what they were at this time last year. Here Andreas Philippi (l), Lower Saxony's minister for social affairs, labor, health and equality, gives the flu vaccine ...

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the ...

In a typical year, several thousand samples from flu patients around the world arrive at the U.S. Centers for Disease Control and Prevention. They're crucial for understanding the virus's evolution ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot. Reading time 3 minutes Next-generation vaccines could make the flu season ...

A Washington resident died of complications from an infection with a bird flu strain never before reported in humans, the state Department of Health said on Friday. The patient was an older adult with ...

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...

A Phase 3 study funded by Pfizer Inc. (NYSE: PFE) suggests that a nucleoside-modified messenger RNA influenza vaccine could offer stronger protection than traditional flu shots, marking a potential ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported. The results, published Nov. 19 in The New England Journal of Medicine, suggest that ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...